Morgan Stanley lowered the firm’s price target on Nutanix (NTNX) to $53 from $56 and keeps an Equal Weight rating on the shares. The “theme of weaker revenue visibility (but solid bookings) returned in Q2, but the culprit was supply-chain issues,” the analyst tells investors. However, a $250M strategic investment and partnership to build an edge inference solution with AMD (AMD), likely “sets a floor on valuation from here,” the analyst added.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Nutanix price target lowered to $50 from $57 at Wells Fargo
- Nutanix price target lowered to $47 from $53 at Barclays
- Nutanix: Strengthening Fundamentals, VMware Replacement Tailwinds, and AI Upside Support a Long-Term Buy Thesis
- Closing Bell Movers: Nvidia pares post-earnings gains
- AMD to invest $150M in Nutanix, announces agentic AI partnership